Controversy Erupts in Study of Eli Lilly ADHD Drug

Australia’s Curtin University of Technology denies that a clinical investigator gave false information to the ethics committee reviewing a study of attention deficit hyperactivity disorder (ADHD) drugs. The university said it was aware before approving the trial that the FDA had ordered a black box warning on the label of one of the study drugs, Eli Lilly’s nonstimulant Strattera (atomoxetine HCl). An Australian newspaper reported that clinical investigator Heather Jenkins falsely told the ethics committee that the FDA had lifted the warning.
Clinical Trials Advisor